Acesion Pharma is a Danish biotech company founded in 2011, aiming for developing more efficacious and safer drugs for the medical treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
Acesion Pharma
Ole Maaløes Vej 3
DK-2200 Copenhagen N
DENMARK
Mail to: contact@acesionpharma.com
CVR-No: 3408 3738